<DOC>
	<DOCNO>NCT00709852</DOCNO>
	<brief_summary>This study involve use Magnetic Resonance Imaging ( MRI ) contrast agent call gadobutrol ( Gadavist ) Injection ProHance Injection . The purpose study look safety ( side effect ) efficacy ( well work ) gadobutrol use take MR image brain spine . The result MRI gadobutrol Injection compare result MR image take without contrast result MR image take ProHance .</brief_summary>
	<brief_title>Safety Efficacy Gadobutrol 1.0 Molar ( Gadavist ) Patients Central Nervous System ( CNS ) Imaging</brief_title>
	<detailed_description>Issues safety address Adverse Events section .</detailed_description>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Central Nervous System Diseases</mesh_term>
	<criteria>Is least 18 year age Is refer contrastenhanced MRI CNS base current clinical symptom result previous imaging procedure Has fully inform study , include provision Health Insurance Portability Accountability Act ( HIPAA ) applicable , consented participate Has contraindication MRI examination use Gdcontaining contrast agent Has history severe allergic anaphylactoid reaction allergen include drug contrast agent Has severe cardiovascular disease ( eg , know long QT syndrome , acute myocardial infarction [ &lt; 14 day ] , unstable angina , congestive heart failure New York Heart Association class IV ) acute stroke ( &lt; 48 hour ) Patients acute renal insufficiency severity due hepatorenal syndrome perioperative liver transplantation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Patients refer contrast-enhanced MRI CNS</keyword>
	<keyword>CNS Imaging</keyword>
</DOC>